---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-040339"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T05:04:09.108460+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioSig closes $2.5M registered direct offering of stock and warrants; net proceeds ~$2.2M

## Summary
- Offered 6,996,922 units (1 share + Series A & B warrants each for 1 share) at $0.3573 per unit.
- Gross proceeds $2.5M; net proceeds ~$2.2M; use for working capital and general corporate purposes.
- Placement agent H.C. Wainwright receives 7% cash fee and warrants for 489,785 shares at $0.4466.
- Series A warrants expire in 5 years, Series B in 18 months; exercisable upon stockholder approval or $0.125 payment.
- Closing occurred November 13, 2023.

## SEC filing metadata
- accession: 0001493152-23-040339
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000149315223040339/0001493152-23-040339-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000149315223040339/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-040339
- JSON: https://secwatch.observer/filing/0001493152-23-040339.json
- Plain text: https://secwatch.observer/filing/0001493152-23-040339.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with institutional investor valued at 6,996,922 shares of common stock at $0.3573 per share, Series A and Series B warrants, aggregate gro (effective 2023-11-08).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: institutional investor
  - Value: 6,996,922 shares of common stock at $0.3573 per share, Series A and Series B warrants, aggregate gro
  - Effective: 2023-11-08
  source text: On November 8, 2023, BioSig Technologies, Inc. (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an institutional investor, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Offering”), (i) 6,996,922 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), (ii) Series A warrants (the “Series A Warrants”) to purchase up to 6,996,922 shares of Common Stock, and (iii) Series B Warrants (the “Series B Warrants”, and together with the Series A Warrants, the “Series Warrants”) to purchase up to 6,996,922 shares of Common Stock, at a purchase price of $0.3573 per Share and associated Series Warrants.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000149315223040339/0001493152-23-040339-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.